Perspective Therapeutics (CATX) Shares Outstanding (2010 - 2026)

Perspective Therapeutics has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $114.0 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 53.97% year-over-year to $114.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $114.0 million (up 53.97% YoY) and the FY2025 annual result came in at $74.3 million, up 5.19% from the prior year.
• Shares Outstanding (Entity) climbed to $114.0 million in Q1 2026 per CATX's latest filing, from $74.3 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $114.0 million in Q1 2026 and troughed at $14.2 million in Q1 2022.
• A 5-year average of $49.4 million and a median of $58.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) advanced 0.05% in 2022, then soared 156.75% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $14.2 million in 2022, then soared by 98.3% to $28.2 million in 2023, then surged by 150.78% to $70.7 million in 2024, then rose by 5.19% to $74.3 million in 2025, then jumped by 53.38% to $114.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $114.0 million, $74.3 million, and $74.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.